Why CDC cuts are being called a ‘gift to tobacco industry’

The Office on Smoking and Health at the CDC is no more, putting state quitlines and national data on youth tobacco use at risk.

April 14, 2025 Check out STAT+

Sponsored By

Adobe Why CDC cuts are being called 'the greatest gift to tobacco industry in the last half-century' CDC closing of Office on Smoking and Health called "greatest gift to the tobacco industry in the last half century" by former OSH director. By Sarah Todd Closure of CDC hepatitis lab imperils U.S. outbreak response, prevention The U.S. capacity to battle hepatitis B and hepatitis C has been leveled a devastating blow. By Helen Branswell Pfizer discontinues its experimental GLP-1 pill Today's biotech news includes the NIH grant bottleneck loosening (a little bit), Pfizer discontinues its experimental GLP-1 pill, and more. By Meghana Keshavan Adobe Tech modernization at community health centers in limbo after federal workforce cuts A tech modernization program at thousands of community health centers across the country is in limbo after the mass firing of federal workers. By Brittany Trang STAT+ | Verve gene-editing therapy lowers cholesterol without serious side effects in early study Initial Phase 1 data show that a single infusion of Verve-102 led to greater decreases in "bad" LDL cholesterol with higher doses. By Elaine Chen STAT+ | How a downturn in biotech may be felt in Kendall Square, an industry hub In Massachusetts, biotech has been a key driver of jobs and wealth for decades, with Kendall Square at the epicenter of that growth. That could change. By Kara Miller — Boston Globe Adobe STAT+ | Opinion: Biotech investors: Stop expecting CRISPR science to make big leaps CRISPR investors are looking for the big home-run hitters, while those with more modest scientific goals are, more often than not, the ones who deliver. By Kelly Banas and Eric B. Kmiec Opinion: 'Most-favored nation' drug pricing has three significant problems "Most-favored nation" drug pricing can't undo the basic economics of the global drug marketplace. By Darius Lakdawalla and Dana P. Goldman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser